2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide

C9H15N3O2S — CID 66147809

IUPAC2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide
SMILESCCCNC(=O)Cn1c(CO)c[nH]c1=S
InChIInChI=1S/C9H15N3O2S/c1-2-3-10-8(14)5-12-7(6-13)4-11-9(12)15/h4,13H,2-3,5-6H2,1H3,(H,10,14)(H,11,15)
InChIKeyTVBNVAXWUPDDDP-UHFFFAOYSA-N
MW229.30 g/mol
LogP0.56
Rot. Bonds5

About 2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide

2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide (PubChem CID 66147809) has the molecular formula C9H15N3O2S and a molecular weight of 229.30 g/mol. Its IUPAC name is 2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide.

Molecular Properties

Compound Name2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide
PubChem CID66147809
Molecular FormulaC9H15N3O2S
Molecular Weight229.30 g/mol
Exact Mass229.09
IUPAC Name2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide
SMILESCCCNC(=O)Cn1c(CO)c[nH]c1=S
InChIInChI=1S/C9H15N3O2S/c1-2-3-10-8(14)5-12-7(6-13)4-11-9(12)15/h4,13H,2-3,5-6H2,1H3,(H,10,14)(H,11,15)
InChIKeyTVBNVAXWUPDDDP-UHFFFAOYSA-N
XLogP0.56
TPSA70.05 Ų
H-Bond Donors3
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms15
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500229.30
LogP ≤ 50.56
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze 2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(2,5-dimethylpyrrol-1-yl)-N-propylacetamide
CID 43567559
2-(5-fluoro-2-sulfanylidene-3H-benzimidazol-1-yl)-N-propylacetamide
CID 43661139
N-ethyl-2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]propanamide
CID 66146356
2-(1,3-dimethyl-5-sulfanylidene-4H-imidazo[4,5-d]pyrazol-6-yl)-N-propylacetamide
CID 79294707
methyl 4-oxo-3-[2-oxo-2-(propylamino)ethyl]-2-sulfanylidene-1H-quinazoline-7-carboxylate
CID 42585654
2-[2-(2-anilino-2-oxoethyl)sulfanyl-5-(hydroxymethyl)imidazol-1-yl]-N-propylacetamide
CID 41341971
2-[2-(hydroxymethyl)imidazol-1-yl]-N-propylacetamide
CID 62222646
N-propyl-2-pyrrolidin-1-ylacetamide
CID 22117904
2-(4-tert-butyl-2-sulfanylidene-1H-imidazol-3-yl)-N-propylpropanamide
CID 81336357
2-methyl-3-[2-oxo-2-(propylamino)ethyl]imidazole-4-carboxylic acid
CID 65173163
3-[5-(hydroxymethyl)imidazol-1-yl]-N-propylpropanamide
CID 66150619
2-[2-[(2-methylpropylamino)methyl]pyrrol-1-yl]-N-propylacetamide
CID 66401260

Frequently Asked Questions

What is the IUPAC name of 2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide?
The IUPAC name of 2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide (CID 66147809) is 2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide.
What is the SMILES notation for 2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide?
The canonical SMILES for 2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide is CCCNC(=O)Cn1c(CO)c[nH]c1=S.
What is the InChIKey of 2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide?
The InChIKey is TVBNVAXWUPDDDP-UHFFFAOYSA-N. The full InChI is InChI=1S/C9H15N3O2S/c1-2-3-10-8(14)5-12-7(6-13)4-11-9(12)15/h4,13H,2-3,5-6H2,1H3,(H,10,14)(H,11,15).
What are the key properties of 2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide?
2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide has a molecular weight of 229.30 g/mol, XLogP of 0.56, 5 rotatable bonds, 3 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(hydroxymethyl)-2-sulfanylidene-1H-imidazol-3-yl]-N-propylacetamide is sourced from PubChem (CID 66147809), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).